Insider · CIK 0002021836
Cristin Hubbard
Files at BMRN (BIOMARIN PHARMACEUTICAL INC). First filing May 6, 2025, latest May 6, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BMRN: BIOMARIN PHARMACEUTICAL INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 0Weak | BIOMARIN PHARMACEUTICAL INC | $18k 273 shares | -1% | +11% from low-27% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +15,410 | $0.00 | $0 | 46,035 | Mar 18, 2026 |
| Mar 17, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -1,245 | $56.05 | $70k | 44,790 | Mar 18, 2026 |
| Mar 16, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +36,680 | $0.00 | $0 | 36,680 | Mar 18, 2026 |
| May 20, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -2,155 | $59.93 | $129k | 30,545 | May 22, 2025 |
| Apr 30, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock10b5-1 | +273 | $54.14 | $15k | 32,973 | May 6, 2025 |
| May 2, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | SOpen-market sale Common Stock10b5-1 | -273 | $64.92 | $18k | 32,700 | May 6, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +13,310 | $0.00 | $0 | 32,700 | Mar 18, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +30,880 | $0.00 | $0 | 30,880 | Mar 18, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.